Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.46 USD | +2.10% | +5.04% | -86.75% |
Apr. 15 | Top Premarket Gainers | MT |
Apr. 12 | Top Premarket Gainers | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 451K |
---|---|---|---|---|---|
Net income 2024 * | -16M | Net income 2025 * | -28M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.05
x | P/E ratio 2025 * |
-0.05
x | Employees | 6 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.98% |
Latest transcript on Allarity Therapeutics, Inc.
1 day | +2.10% | ||
1 week | +5.04% | ||
Current month | -75.76% | ||
1 month | -76.38% | ||
3 months | -83.02% | ||
6 months | -87.75% | ||
Current year | -86.75% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Jensen
FOU | Founder | 46 | 20-05-31 |
Joan Brown
DFI | Director of Finance/CFO | 71 | 21-09-20 |
Chief Tech/Sci/R&D Officer | 63 | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 56 | 22-09-30 | |
Thomas Jensen
FOU | Founder | 46 | 20-05-31 |
Joseph Vazzano
BRD | Director/Board Member | 40 | 23-07-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.46 | +2.10% | 188,287 |
24-04-25 | 1.43 | +4.38% | 223,259 |
24-04-24 | 1.37 | -3.52% | 264,036 |
24-04-23 | 1.42 | 0.00% | 805,840 |
24-04-22 | 1.42 | +2.16% | 743,436 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.75% | 451K | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ALLR Stock